Sergio Collazo
General Practice · Tampa, FLNPI 1619531027
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AstraZeneca at 24.1% of the total. Reporting peaked in 2024 at $824 and has fallen 69.8% since, to $249 in 2025. Among general practice clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 152 payments — averaging $21.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$797
- Novo Nordisk$681
- Johnson & Johnson$487
- Bayer$305
- AbbVie$141
- GSK$121
- plus $780 from 16 others
What the payments were for
- Food & beverage$3,313100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $797 |
| Novo Nordisk | 36 | $681 |
| Johnson & Johnson | 22 | $487 |
| Bayer | 16 | $305 |
| AbbVie | 7 | $141 |
| GSK | 7 | $121 |
| Amgen | 7 | $120 |
| Genentech USA, Inc. | 1 | $113 |
| Exact Sciences | 5 | $101 |
| Boehringer Ingelheim | 5 | $88 |
| Lilly USA, LLC | 5 | $84 |
| Lundbeck LLC | 3 | $66 |
| Almatica Pharma LLC | 2 | $30 |
| Hologic Sales And Service, LLC | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Averitas Pharma Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
| Pfizer | 1 | $19 |
| Eisai Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,313 in reported general payments places this provider in the 95th percentile of 6,901 general practice providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 35 | $58,348 |
| FarxigaDapagliflozin Propanediol | 52 | $49,225 |
| TrulicityDulaglutide | 26 | $39,525 |
| EliquisApixaban | 30 | $39,356 |
| JardianceEmpagliflozin | 27 | $35,410 |
| JanuviaSitagliptin Phosphate | 13 | $11,969 |
| LinzessLinaclotide | 12 | $8,417 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $7,891 |
| DapagliflozinDapagliflozin Propanediol | 13 | $7,717 |
| SymbicortBudesonide/Formoterol Fumarate | 21 | $6,967 |
| Spiriva HandihalerTiotropium Bromide | 12 | $6,184 |
| Diclofenac Sodium | 101 | $4,114 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 46 | $4,017 |
| Omeprazole | 180 | $2,674 |
| Levemir FlexpenInsulin Detemir | 14 | $2,528 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $681 | $58,34835 claims |
| AstraZenecaFarxiga, Symbicort | $797 | $56,19273 claims |
| Lilly USA, LLCTrulicity | $84 | $39,52526 claims |
| PfizerEliquis | $19 | $39,35630 claims |
| Boehringer IngelheimJardiance | $88 | $35,41027 claims |
| AbbVieLinzess | $141 | $8,41712 claims |
| GSKBreo Ellipta | $121 | $7,89111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,901 general practice providers in Florida.
Other general practice in Tampa
- Sarah JockinTampa$308K
- Jeffrey HuntTampa$78K
- Robert VogelPalm Beach Gardens$1M
- Bruce OuelletteWest Palm Beach$724K
- Caley CasteleinMiami Beach$586K
- Mario RomeroSarasota$275K
- Robert RitterJupiter$233K
- Robert AltharPensacola$231K
- Florencia ZiemkeWest Palm Beach$208K
- Ausberto HidalgoPembroke Pines$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.